To overcome the side effects of steroids, novel steroid-17-yl methyl glycolates with succinyl group at C-20, derived from predinisolone and dexamethasone were prepared based on concept of the antedrug. Their topical anti-inflammatory activity and systemic effects were evaluated trough croton oil-induced ear edema and paper disk granuloma bioassay. Among them, (20S)-succinyl dexamethasone derivatives (7 and 11) indicated more potent ati-inflammatory activity than the parent dexamethasone and did not show corticosteroidal side effects of thymic, adrenal involution or body weight loss. Both 7 and 11 were immediately metabolized into active compound 3 and this metabolite was eliminated with mean half-lives of 0.786 to 0.866 h in rat serum. Our findings suggest that these two compounds might be candidates as the novel steroids, and that that introduction of the succinyl group into the methyl glycolates at C-20 is useful to avoid suppressiion of organs due to the side effects of corticosteroids.
为了克服类
固醇的副作用,研究人员根据抗药物的概念,从predinisolone和
地塞米松中提取出了C-20位琥珀酰基的新型类
固醇-17-基甲基羟基化合物。通过
巴豆油诱导的耳
水肿和纸盘肉芽肿
生物测定评估了它们的局部抗炎活性和全身作用。其中,(20S)-琥珀酰
地塞米松衍
生物(7 和 11)比母体
地塞米松具有更强的抗炎活性,而且不会出现胸腺、肾上腺萎缩或体重减轻等皮质类
固醇副作用。7 和 11 会立即代谢为活性化合物 3,这种代谢物在大鼠血清中的平均半衰期为 0.786 至 0.866 小时。我们的研究结果表明,这两种化合物可能是新型类
固醇的候选化合物,在甲基羟基化合物的 C-20 处引入琥珀酰基有助于避免皮质类
固醇的副作用对器官的抑制。